{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:35:00Z","timestamp":1771403700126,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Yancheng Medical Science Development Foundation","award":["YK2014084"],"award-info":[{"award-number":["YK2014084"]}]},{"name":"Yancheng Medical Science Development Foundation","award":["YK2016090"],"award-info":[{"award-number":["YK2016090"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.09.018","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T23:31:51Z","timestamp":1505345511000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model"],"prefix":"10.1016","volume":"95","author":[{"given":"Guangping","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shidai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengshun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.09.018_bib0005","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2017.09.018_bib0010","first-page":"9","article-title":"Cancer statistics 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2017.09.018_bib0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12885-016-2345-7","article-title":"Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer","volume":"16","author":"Diessner","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2017.09.018_bib0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5306\/wjco.v5.i3.335","article-title":"Molecular pathogenesis of bone metastases in breast cancer: proven and emerging therapeutic targets","volume":"5","author":"Rucci","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0025","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/annonc\/mdv284","article-title":"Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis","volume":"26","author":"Ibrahim","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cell.2013.08.020","article-title":"Breast cancer bone metastases: it\u2019s all about the neighborhood","volume":"154","author":"Guise","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.09.018_bib0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast","volume":"133","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.09.018_bib0040","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","article-title":"Molecular basis of metastasis","volume":"359","author":"Chiang","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2017.09.018_bib0045","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-13-0838","article-title":"Metastasis dormancy in estrogen receptor-positive breast cancer","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2017.09.018_bib0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12885-015-1528-y","article-title":"The breast cancer to bone (B2B) metastases research program: a multi-disciplinary investigation of bone metastases from breast cancer","volume":"15","author":"Brockton","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2017.09.018_bib0055","article-title":"1,25(OH)2D3 deficiency induces colon inflammation via secretion of senescence-associated inflammatory cytokines","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.09.018_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamaoncol.2016.4188","article-title":"Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study","volume":"3","author":"Yao","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0065","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/ijc.28628","article-title":"Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: influence of tumor characteristics and lifestyle factors","volume":"134","author":"Vrieling","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2017.09.018_bib0070","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/bjc.2014.175","article-title":"Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis","volume":"110","author":"Kim","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2017.09.018_bib0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2105\/AJPH.2004.045260","article-title":"The role of vitamin D in cancer prevention","volume":"96","author":"Garland","year":"2006","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.biopha.2017.09.018_bib0080","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1073\/pnas.131029498","article-title":"Targeted ablation of the 25-hydroxyvitamin D 1alpha\u2013hydroxylase enzyme: evidence forskeletal, reproductive, and immune dysfunction","volume":"98","author":"Panda","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.09.018_bib0085","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1359\/JBMR.050608","article-title":"Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice","volume":"20","author":"Xue","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2017.09.018_bib0090","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/ddi160","article-title":"Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development","volume":"14","author":"Xue","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2017.09.018_bib0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bone.2010.07.012","article-title":"Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis","volume":"47","author":"Ooi","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2017.09.018_bib0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-642-21892-7_11","article-title":"Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum?","volume":"192","author":"Ortiz","year":"2012","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.biopha.2017.09.018_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumors","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.09.018_bib0110","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1245\/s10434-010-1465-6","article-title":"Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer","volume":"18","author":"Kim","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.beem.2011.05.001","article-title":"The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3","volume":"25","author":"Vanoirbeek","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2017.09.018_bib0120","first-page":"5711","article-title":"Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen","volume":"54","author":"Vink-van Wijngaarden","year":"1994","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.018_bib0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.09.018_bib0130","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1200\/JCO.2008.18.4184","article-title":"Cancer treatment-induced bone loss in breast and prostate cancer","volume":"26","author":"Saad","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0135","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/1078-0432.CCR-13-1246","article-title":"Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo","volume":"20","author":"Ottewell","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2017.09.018_bib0140","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/annonc\/mdn164","article-title":"Practical guidance for the management of aromatase inhibitor-associated bone loss","volume":"19","author":"Hadji","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdw544","article-title":"3rd ESO-ESMO international consensus guidelines for advanced Breast cancer (ABC 3)","volume":"28","author":"Cardoso","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0150","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1080\/01635581.2016.1213868","article-title":"1\u03b1,25-Dihydroxyvitamin d inhibits the metastatic capability of MCF10CA1a and MDA-MB-231cells in an In vitro model of Breast to bone metastasis","volume":"68","author":"Wilmanski","year":"2016","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biopha.2017.09.018_bib0155","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/0008-5472.CAN-09-3194","article-title":"Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis","volume":"70","author":"Ooi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2017.09.018_bib0160","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","article-title":"Molecular basis of metastasis","volume":"359","author":"Chiang","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2017.09.018_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2012.10.005","article-title":"SnapShot: bone metastasis","volume":"151","author":"Ell","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.09.018_bib0170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/07357907.2015.1065500","article-title":"Animal models for breast cancer metastasis to bone: opportunities and limitations","volume":"33","author":"Horas","year":"2015","journal-title":"Cancer Invest."},{"key":"10.1016\/j.biopha.2017.09.018_bib0175","article-title":"Preclinical orthotopic and intracardiac injection models of human breast cancer metastasis to bone and their use in drug discovery","volume":"14","author":"Scepansky","year":"2011","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.biopha.2017.09.018_bib0180","first-page":"e4260","article-title":"Models of bone metastasis","volume":"67","author":"Campbell","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2017.09.018_bib0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/CGM.S11284","article-title":"Animal cancer models of skeletal metastasis","volume":"6","author":"Hibberd","year":"2013","journal-title":"Cancer Growth Metast."},{"key":"10.1016\/j.biopha.2017.09.018_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-\u03b2 in cancer and bone: implications for treatment of bone metastases","volume":"48","author":"Ju\u00e1rez","year":"2011","journal-title":"Bone"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217332316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217332316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:50:36Z","timestamp":1771401036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217332316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":38,"alternative-id":["S0753332217332316"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.018","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}